Literature DB >> 15771688

Vasopressin in the treatment of vasodilatory shock in children.

Satoshi Masutani1, Hideaki Senzaki, Hirotaka Ishido, Mio Taketazu, Tamotsu Matsunaga, Toshiki Kobayashi, Nozomu Sasaki, Haruhiko Asano, Shunei Kyo, Yuji Yokote.   

Abstract

BACKGROUND: Many recent studies suggest that vasopressin deficiency is an important cause of catecholamine-resistant hypotension with vasodilation in adults, but little is known about vasopressin deficiency in children.
METHODS: To clarify the usefulness of vasopressin administration in pediatric cathecolamine-resistant hypotension with preserved ventricular contractility, urinary output and blood pressure response to vasopressin were retrospectively analyzed in 12 consecutive patients (15 instances) who were treated with vasopressin. The causes of vasodilation were central nervous system disturbance (n = 5), side-effect of drug (n = 5), and infection (n = 5). Plasma vasopressin concentration was measured six times before vasopressin administration and five times during vasopressin administration.
RESULTS: Patients were divided into four groups according to their response to vasopressin administration. In group 1 (n = 5), urinary output increased to > 3 mL/kg per h within 3 h after vasopressin administration. In group 2 (n = 4), urinary output increased to > 3 mL/kg per h from 3 to 5 h after vasopressin administration. In group 3 (n = 4), urinary output did not increase to > 3 mL/kg per min within 5 h after vasopressin administration, but systolic blood pressure increased to > 120% of the level at the time of vasopressin administration. All remaining patients were classified into group 4 (n = 3). Plasma vasopressin concentration were low considering the markedly hypotensive state in all six instances. Plasma vasopressin concentration during vasopressin administration were significantly increased compared with before administration (P < 0.05). No apparent side-effects were observed in this series.
CONCLUSION: Vasopressin deficiency may occur in catecholamine-resistant hypotension of pediatric patients due to various causes including central nervous system disturbance, drug induced hypotension and sepsis. Small doses of vasopressin administration seems to be very effective in such conditions by increasing blood pressure and urinary output.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771688     DOI: 10.1111/j.1442-200x.2005.02043.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  16 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Arginine-vasopressin as a rescue therapy in children and neonates for catecholamine-resistant shock.

Authors:  Sascha Meyer; Sven Gottschling; Ludwig Gortner
Journal:  Eur J Pediatr       Date:  2007-04-12       Impact factor: 3.183

4.  Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.

Authors:  Evelyn Lechner; Anna Hofer; Rudolf Mair; Werner Moosbauer; Eva Sames-Dolzer; Gerald Tulzer
Journal:  Eur J Pediatr       Date:  2007-01-16       Impact factor: 3.183

5.  Successful management of the persistent pulmonary hypertension of the newborn with transposition of the great arteries by restricted patency of the ductus arteriosus: a simple and rational novel strategy.

Authors:  Satoshi Masutani; Mitsuru Seki; Mio Taketazu; Hideaki Senzaki
Journal:  Pediatr Cardiol       Date:  2009-06-04       Impact factor: 1.655

6.  The impact of intraoperative vasopressin infusion in complex neonatal cardiac surgery.

Authors:  Shinichi Nishibe; Miki Tsujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-09-07

7.  Refractory hypotension after bilateral nephrectomies in a Denys-Drash patient with phenylketonuria.

Authors:  Amanda B Hassinger; Sudha Garimella
Journal:  Pediatr Nephrol       Date:  2012-09-20       Impact factor: 3.714

8.  Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.

Authors:  Stephanie M Boyd; Kristin L Riley; Regan E Giesinger; Patrick J McNamara
Journal:  J Perinatol       Date:  2020-09-19       Impact factor: 2.521

9.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

10.  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.

Authors:  Nameet Jerath; Helena Frndova; Brian W McCrindle; Rebecca Gurofsky; Tilman Humpl
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.